{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:31:29Z","timestamp":1790983889799,"version":"4.1.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>The Sequential Organ Failure Assessment (SOFA) score originated as a tool for assessing organ dysfunction in critical illness but has expanded to become an outcome measure in clinical trials. We aimed to assess how the SOFA score was used as the primary or secondary endpoint of major randomized controlled trials (RCTs).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>Independent reviewers searched MEDLINE\/PubMed, Scopus, and Embase databases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>STUDY SELECTION:<\/jats:title>\n            <jats:p>Articles were selected when they fulfilled: 1) RCT; 2) SOFA score was primary or secondary endpoint; and 3) published in the <jats:italic toggle=\"yes\">Lancet<\/jats:italic>, <jats:italic toggle=\"yes\">New England Journal of Medicine<\/jats:italic>, or <jats:italic toggle=\"yes\">Journal of the American Medical Association<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA EXTRACTION:<\/jats:title>\n            <jats:p>Data collection included study details, outcomes, statistical differences in SOFA score, choice of score statistics, timepoints of SOFA reporting, and how missing data and competing risks analysis were managed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SYNTHESIS:<\/jats:title>\n            <jats:p>Twenty-three RCTs had SOFA score as outcome measure, eight used it as primary endpoint. Daily maximum SOFA was the key statistic in 11 RCTs, delta SOFA was used in eight, and mean SOFA in four. Mean SOFA was most frequently chosen as primary endpoint (4\/8, 50%). There were 18 different outcome assessment timepoints, ranging from 1 to 28 days. Three RCTs reported statistically significant difference in SOFA between groups. Handling of missing SOFA scores was not described in ten of 23 RCTs. When described, it varied from study to study with variable imputation methods and variable accounting for the competing risk of mortality and ICU discharge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>There is major variability in the choice of summary statistic for SOFA score analysis and assessment timepoints, when using it as outcome measure in RCTs. There was either no information or great variability in the handling of missing values, use of imputation, and accounting for competing risk. The current use of SOFA scores in RCTs lacks sufficient reproducibility and statistical and methodological robustness.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000006532","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T22:00:09Z","timestamp":1733349609000},"page":"e1116-e1124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Mastering the Sequential Organ Failure Assessment Score: Critical Choices of Score Statistic, Timing, Imputations, and Competing Risk Handling in Major Trials\u2014A Systematic Review"],"prefix":"10.1097","volume":"53","author":[{"given":"Marilena","family":"Marmiere","sequence":"first","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"D\u2019Amico","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Monti","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."},{"name":"Vita-Salute San Raffaele University, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-5980","authenticated-orcid":false,"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy."},{"name":"Vita-Salute San Raffaele University, Milan, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"R1-20250506","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"R2-20250506","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/00003246-199811000-00016","article-title":"Use of the SOFA score to assess the incidence of organ dysfunction\/failure in intensive care units: Results of a multicenter, prospective study. Working group on \u201csepsis-related problems\u201d of the European Society of Intensive Care Medicine.","volume":"26","author":"Vincent","year":"1998","journal-title":"Crit Care Med"},{"key":"R3-20250506","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13054-022-04290-9","article-title":"The Sequential Organ Failure Assessment (SOFA) score: Has the time come for an update?","volume":"27","author":"Moreno","year":"2023","journal-title":"Crit Care"},{"key":"R4-20250506","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R5-20250506","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock.","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"R6-20250506","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients.","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"key":"R7-20250506","first-page":"5","article-title":"The value of clinical scores in predicting mortality of adult patients on veno-arterial extracorporeal membrane oxygenation.","volume":"18","author":"Mohamed","year":"2022","journal-title":"Signa Vitae"},{"key":"R8-20250506","article-title":"Guideline on Clinical Investigation of Medicinal Products for the Treatment of Sepsis."},{"key":"R9-20250506","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1097\/00003246-200208000-00005","article-title":"Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill.","volume":"30","author":"Pettila","year":"2002","journal-title":"Crit Care Med"},{"key":"R10-20250506","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s13054-019-2663-7","article-title":"The SOFA score-development, utility and challenges of accurate assessment in clinical trials.","volume":"23","author":"Lambden","year":"2019","journal-title":"Crit Care"},{"key":"R11-20250506","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R12-20250506","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0895-4356(94)00172-M","article-title":"Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis.","volume":"48","author":"Cook","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"R13-20250506","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-126-5-199703010-00006","article-title":"Systematic reviews: Synthesis of best evidence for clinical decisions.","volume":"126","author":"Cook","year":"1997","journal-title":"Ann Intern Med"},{"key":"R15-20250506","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R16-20250506","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R17-20250506","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.2023.20134","article-title":"Landiolol and organ failure in patients with septic shock: The STRESS-L randomized clinical trial.","volume":"330","author":"Whitehouse","year":"2023","journal-title":"JAMA"},{"key":"R18-20250506","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jama.2021.13011","article-title":"Effect of low-normal vs high-normal oxygenation targets on organ dysfunction in critically ill patients: A randomized clinical trial.","volume":"326","author":"Gelissen","year":"2021","journal-title":"JAMA"},{"key":"R19-20250506","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.2020.11946","article-title":"Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: The ACTS randomized clinical trial.","volume":"324","author":"Moskowitz","year":"2020","journal-title":"JAMA"},{"key":"R20-20250506","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial.","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"},{"key":"R21-20250506","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis.","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"R22-20250506","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","article-title":"Levosimendan for the prevention of acute organ dysfunction in sepsis.","volume":"375","author":"Gordon","year":"2016","journal-title":"N Engl J Med"},{"key":"R23-20250506","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1001\/jama.2012.5833","article-title":"Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: A randomized trial.","volume":"307","author":"Brunkhorst","year":"2012","journal-title":"JAMA"},{"key":"R24-20250506","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(09)60949-1","article-title":"Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial.","volume":"374","author":"Jabre","year":"2009","journal-title":"Lancet"},{"key":"R25-20250506","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension.","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"R26-20250506","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa2200644","article-title":"Intravenous vitamin C in adults with sepsis in the intensive care unit.","volume":"386","author":"Lamontagne","year":"2022","journal-title":"N Engl J Med"},{"key":"R27-20250506","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: The CoDEX randomized clinical trial.","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"R28-20250506","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2019.0071","article-title":"Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial.","volume":"321","author":"Hern\u00e1ndez","year":"2019","journal-title":"JAMA"},{"key":"R29-20250506","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial.","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"key":"R30-20250506","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock.","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R31-20250506","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.2017.2088","article-title":"Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: A randomized clinical trial.","volume":"317","author":"Kawazoe","year":"2017","journal-title":"JAMA"},{"key":"R32-20250506","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, candida colonization, and multiple organ failure: The EMPIRICUS randomized clinical trial.","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"R33-20250506","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: A randomized clinical trial.","volume":"314","author":"Lemiale","year":"2015","journal-title":"JAMA"},{"key":"R34-20250506","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jama.2014.7698","article-title":"High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: A randomized clinical trial.","volume":"312","author":"van Zanten","year":"2014","journal-title":"JAMA"},{"key":"R35-20250506","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.2013.280031","article-title":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: A randomized clinical trial.","volume":"310","author":"Papazian","year":"2013","journal-title":"JAMA"},{"key":"R36-20250506","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jama.2010.2","article-title":"Corticosteroid treatment and intensive insulin therapy for septic shock in adults: A randomized controlled trial.","volume":"303","author":"Annane","year":"2010","journal-title":"JAMA"},{"key":"R37-20250506","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial.","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"R38-20250506","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: A randomised trial.","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"key":"R39-20250506","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jama.2023.10598","article-title":"Continuous vs intermittent meropenem administration in critically ill patients with sepsis: The MERCY randomized clinical trial.","volume":"330","author":"Monti","year":"2023","journal-title":"JAMA"},{"key":"R40-20250506","doi-asserted-by":"crossref","first-page":"106346","DOI":"10.1016\/j.cct.2021.106346","article-title":"Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design.","volume":"104","author":"Monti","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"R41-20250506","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13054-017-1609-1","article-title":"SOFA and mortality endpoints in randomized controlled trials: A systematic review and meta-regression analysis.","volume":"21","author":"de Grooth","year":"2017","journal-title":"Crit Care"},{"key":"R42-20250506","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1126\/science.103.2684.677","article-title":"On the theory of scales of measurement.","volume":"103","author":"Stevens","year":"1946","journal-title":"Science"},{"key":"R43-20250506","doi-asserted-by":"crossref","first-page":"16160","DOI":"10.1038\/s41598-024-67089-4","article-title":"Observational study of missing SOFA score data frequency in RCTs relative to ICU length of stay.","volume":"14","author":"Molinnus","year":"2024","journal-title":"Sci Rep"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T14:00:11Z","timestamp":1746540011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000006532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000006532","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]}}}